C.B. Lücking

1.5k total citations
9 papers, 573 citations indexed

About

C.B. Lücking is a scholar working on Neurology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, C.B. Lücking has authored 9 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 7 papers in Cellular and Molecular Neuroscience and 3 papers in Neurology. Recurrent topics in C.B. Lücking's work include Parkinson's Disease Mechanisms and Treatments (8 papers), Nuclear Receptors and Signaling (5 papers) and Neurological diseases and metabolism (3 papers). C.B. Lücking is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (8 papers), Nuclear Receptors and Signaling (5 papers) and Neurological diseases and metabolism (3 papers). C.B. Lücking collaborates with scholars based in France, Germany and Netherlands. C.B. Lücking's co-authors include Alexis Brice, Patrice Denèfle, Jan Booij, M.W.I.M. Horstink, Bart P.C. van de Warrenburg, Martin Lammens, Pieter Wesseling, Niall Quinn, Pierre Pollak and Alexandra Dürr and has published in prestigious journals such as Neurology, FEBS Letters and Cellular and Molecular Life Sciences.

In The Last Decade

C.B. Lücking

9 papers receiving 562 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C.B. Lücking France 6 455 260 155 142 128 9 573
Petra Leitner Germany 6 359 0.8× 145 0.6× 161 1.0× 106 0.7× 115 0.9× 7 459
Christoph B. Lücking Germany 9 385 0.8× 286 1.1× 155 1.0× 55 0.4× 127 1.0× 11 502
Robert Hering Germany 6 360 0.8× 279 1.1× 137 0.9× 65 0.5× 101 0.8× 8 471
Shabnam Salehi‐Rad Canada 11 457 1.0× 211 0.8× 249 1.6× 217 1.5× 164 1.3× 13 660
Sabine Kauffmann Switzerland 4 409 0.9× 307 1.2× 100 0.6× 119 0.8× 86 0.7× 4 495
Fariba Chegini Australia 12 383 0.8× 179 0.7× 292 1.9× 272 1.9× 95 0.7× 13 699
Wei-Ping Gai Australia 13 226 0.5× 157 0.6× 116 0.7× 151 1.1× 89 0.7× 13 440
Joseph Wiley Canada 6 403 0.9× 142 0.5× 127 0.8× 103 0.7× 157 1.2× 7 460
Magali Periquet France 7 591 1.3× 411 1.6× 183 1.2× 97 0.7× 165 1.3× 7 696
Janel Johnson United States 10 389 0.9× 290 1.1× 235 1.5× 121 0.9× 141 1.1× 15 585

Countries citing papers authored by C.B. Lücking

Since Specialization
Citations

This map shows the geographic impact of C.B. Lücking's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.B. Lücking with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.B. Lücking more than expected).

Fields of papers citing papers by C.B. Lücking

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.B. Lücking. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.B. Lücking. The network helps show where C.B. Lücking may publish in the future.

Co-authorship network of co-authors of C.B. Lücking

This figure shows the co-authorship network connecting the top 25 collaborators of C.B. Lücking. A scholar is included among the top collaborators of C.B. Lücking based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.B. Lücking. C.B. Lücking is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lücking, C.B., Peter Lichtner, Edgar R. Kramer, et al.. (2008). Polymorphisms in the receptor for GDNF (RET) are not associated with Parkinson's disease in Southern Germany. Neurobiology of Aging. 31(1). 167–168. 3 indexed citations
2.
Unschuld, Paul G., Justus C. Dächsel, Frédéric Darios, et al.. (2006). Parkin Modulates Gene Expression in Control and Ceramide-Treated PC12 Cells. Molecular Biology Reports. 33(1). 13–32. 22 indexed citations
3.
Dächsel, Justus C., C.B. Lücking, Maciej Łałowski, et al.. (2005). Parkin interacts with the proteasome subunit α4. FEBS Letters. 579(18). 3913–3919. 39 indexed citations
4.
Warrenburg, Bart P.C. van de, Martin Lammens, C.B. Lücking, et al.. (2001). Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations. Neurology. 56(4). 555–557. 210 indexed citations
5.
Lücking, C.B., Vincenzo Bonifati, Magali Periquet, et al.. (2001). Pseudo-dominant inheritance and exon 2 triplication in a family with parkin gene mutations. Neurology. 57(5). 924–927. 34 indexed citations
6.
Lücking, C.B. & Alexis Brice. (2000). Alpha-synuclein and Parkinson's disease. Cellular and Molecular Life Sciences. 57(13). 1894–1908. 223 indexed citations
7.
Broussolle, E., C.B. Lücking, Nathalie Ginovart, et al.. (2000). [ 18 F]-dopa PET study in patients with juvenile-onset PD and parkin gene mutations. Neurology. 55(6). 877–879. 39 indexed citations
8.
Kösel, Siegfried, C.B. Lücking, Rupert Egensperger, P. Mehraein, & Manuel B. Graeber. (1996). Mitochondrial NADH dehydrogenase and CYP2D6 genotypes in Lewy‐body Parkinsonism. Journal of Neuroscience Research. 44(2). 174–183. 1 indexed citations
9.
Rascol, Olivier, Nelly Fabre, H. Teräväinen, et al.. (1990). CQA 206–291. Clinical Neuropharmacology. 13(4). 303–311. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026